Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Eligo Bioscience has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Eligo Bioscience's investors include Bpifrance, Khosla Ventures, Seventure Partners, Sanofi Ventures, CARB-X.
Eligo Bioscience is headquartered in Paris, France.
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Eligo Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eligo Bioscience — Funding & Investors." VCBacked, May 13, 2025, https://www.vcbacked.co/company/eligo-bioscience. Accessed July 20, 2026.
VCBacked. (2025). Eligo Bioscience — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/eligo-bioscience
{{cite web |title=Eligo Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/eligo-bioscience |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated